Requirement of the ATM/p53 Tumor Suppressor Pathway for Glucose Homeostasis

REFERENCES

• Armata, H. L., D. S. Garlick, and H. K. Sluss. 2007. The ataxia telangiectasia-mutated target site Ser18 is required for p53-mediated tumor suppression. Cancer Res. 67:11696–11703.
   PubMed Web of Science ®Google Scholar
• Balaban, R. S., S. Nemoto, and T. Finkel. 2005. Mitochondria, oxidants, and aging. Cell 120:483–495.
   PubMed Web of Science ®Google Scholar
• Bar, R. S., W. R. Levis, M. M. Rechler, L. C. Harrison, C. Siebert, J. Podskalny, J. Roth, and M. Muggeo. 1978. Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N. Engl. J. Med. 298:1164–1171.
   PubMed Web of Science ®Google Scholar
• Barlow, C., P. A. Dennery, M. K. Shigenaga, M. A. Smith, J. D. Morrow, L. J. Roberts III, A. Wynshaw-Boris, and R. L. Levine. 1999. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. U. S. A. 96:9915–9919.
   PubMed Web of Science ®Google Scholar
• Barlow, C., S. Hirotsune, R. Paylor, M. Liyanage, M. Eckhaus, F. Collins, Y. Shiloh, J. N. Crawley, T. Ried, D. Tagle, and A. Wynshaw-Boris. 1996. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell 86:159–171.
   PubMed Web of Science ®Google Scholar
• Bastard, J. P., M. Maachi, C. Lagathu, M. J. Kim, M. Caron, H. Vidal, J. Capeau, and B. Feve. 2006. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur. Cytokine Netw. 17:4–12.
   PubMed Web of Science ®Google Scholar
• Bensaad, K., and K. H. Vousden. 2007. p53: new roles in metabolism. Trends Cell Biol. 17:286–291.
   PubMed Web of Science ®Google Scholar
• Bensaad, K., and K. H. Vousden. 2005. Savior and slayer: the two faces of p53. Nat. Med. 11:1278–1279.
   PubMed Web of Science ®Google Scholar
• Budanov, A. V., A. A. Sablina, E. Feinstein, E. V. Koonin, and P. M. Chumakov. 2004. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 304:596–600.
   PubMed Web of Science ®Google Scholar
• Chao, C., S. Saito, C. W. Anderson, E. Appella, and Y. Xu. 2000. Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc. Natl. Acad. Sci. U. S. A. 97:11936–11941.
   PubMed Web of Science ®Google Scholar
• Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, Jr., J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215–221.
   PubMed Web of Science ®Google Scholar
• Eizenberg, O., A. Faber-Elman, E. Gottlieb, M. Oren, V. Rotter, and M. Schwartz. 1995. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J. 14:1136–1144.
   PubMed Web of Science ®Google Scholar
• Frederich, R. C., A. Hamann, S. Anderson, B. Lollmann, B. B. Lowell, and J. S. Flier. 1995. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat. Med. 1:1311–1314.
   PubMed Web of Science ®Google Scholar
• Fridlyand, L. E., and L. H. Philipson. 2006. Reactive species and early manifestation of insulin resistance in type 2 diabetes. Diabetes Obes. Metab. 8:136–145.
   PubMed Web of Science ®Google Scholar
• Gatei, M., D. Shkedy, K. K. Khanna, T. Uziel, Y. Shiloh, T. K. Pandita, M. F. Lavin, and G. Rotman. 2001. Ataxia-telangiectasia: chronic activation of damage-responsive functions is reduced by alpha-lipoic acid. Oncogene 20:289–294.
   PubMed Web of Science ®Google Scholar
• Giorgio, M., M. Trinei, E. Migliaccio, and P. G. Pelicci. 2007. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? Nat. Rev. Mol. Cell Biol. 8:722–728.
   PubMed Web of Science ®Google Scholar
• Golden, T. R., D. A. Hinerfeld, and S. Melov. 2002. Oxidative stress and aging: beyond correlation. Aging Cell 1:117–123.
   PubMed Web of Science ®Google Scholar
• Ito, K., K. Takubo, F. Arai, H. Satoh, S. Matsuoka, M. Ohmura, K. Naka, M. Azuma, K. Miyamoto, K. Hosokawa, Y. Ikeda, T. W. Mak, T. Suda, and A. Hirao. 2007. Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes. J. Immunol. 178:103–110.
   PubMed Web of Science ®Google Scholar
• Jones, R. G., D. R. Plas, S. Kubek, M. Buzzai, J. Mu, Y. Xu, M. J. Birnbaum, and C. B. Thompson. 2005. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol. Cell 18:283–293.
   PubMed Web of Science ®Google Scholar
• Kamsler, A., D. Daily, A. Hochman, N. Stern, Y. Shiloh, G. Rotman, and A. Barzilai. 2001. Increased oxidative stress in ataxia telangiectasia evidenced by alterations in redox state of brains from Atm-deficient mice. Cancer Res. 61:1849–1854.
   PubMed Web of Science ®Google Scholar
• Kastan, M. B., and D. S. Lim. 2000. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1:179–186.
   PubMed Web of Science ®Google Scholar
• Kawagishi, H., T. Wakoh, H. Uno, M. Maruyama, A. Moriya, S. Morikawa, H. Okano, C. J. Sherr, M. Takagi, and M. Sugimoto. 2008. Hzf regulates adipogenesis through translational control of C/EBPalpha. EMBO J. 27:1481–1490.
   PubMed Web of Science ®Google Scholar
• Kim, H. J., T. Higashimori, S. Y. Park, H. Choi, J. Dong, Y. J. Kim, H. L. Noh, Y. R. Cho, G. Cline, Y. B. Kim, and J. K. Kim. 2004. Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes 53:1060–1067.
   PubMed Web of Science ®Google Scholar
• Kondoh, H., M. E. Lleonart, J. Gil, J. Wang, P. Degan, G. Peters, D. Martinez, A. Carnero, and D. Beach. 2005. Glycolytic enzymes can modulate cellular life span. Cancer Res. 65:177–185.
   PubMed Web of Science ®Google Scholar
• Lavin, M. F. 2008. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signaling and cancer. Nat. Rev. Mol. Cell Biol. 9:759–769.
   PubMed Web of Science ®Google Scholar
• Lee, C. H., K. Inoki, M. Karbowniczek, E. Petroulakis, N. Sonenberg, E. P. Henske, and K. L. Guan. 2007. Constitutive mTOR activation in TSC mutants sensitizes cells to energy starvation and genomic damage via p53. EMBO J. 26:4812–4823.
   PubMed Web of Science ®Google Scholar
• Liu, B., Y. Chen, and D. K. St. Clair. 2008. ROS and p53: a versatile partnership. Free Radic. Biol. Med. 44:1529–1535.
   PubMed Web of Science ®Google Scholar
• Matheu, A., A. Maraver, P. Klatt, I. Flores, I. Garcia-Cao, C. Borras, J. M. Flores, J. Vina, M. A. Blasco, and M. Serrano. 2007. Delayed ageing through damage protection by the Arf/p53 pathway. Nature 448:375–379.
   PubMed Web of Science ®Google Scholar
• Matoba, S., J. G. Kang, W. D. Patino, A. Wragg, M. Boehm, O. Gavrilova, P. J. Hurley, F. Bunz, and P. M. Hwang. 2006. p53 regulates mitochondrial respiration. Science 312:1650–1653.
   PubMed Web of Science ®Google Scholar
• Mercer, J., N. Figg, V. Stoneman, D. Braganza, and M. R. Bennett. 2005. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice. Circ. Res. 96:667–674.
   PubMed Web of Science ®Google Scholar
• Minamino, T., M. Orimo, I. Shimizu, T. Kunieda, M. Yokoyama, T. Ito, A. Nojima, A. Nabetani, Y. Oike, H. Matsubara, F. Ishikawa, and I. Komuro. 2009. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat. Med. 15:1082–1087.
   PubMed Web of Science ®Google Scholar
• Moon, C., S. Kim, M. Wie, H. Kim, J. Cheong, J. Park, Y. Jee, N. Tanuma, Y. Matsumoto, and T. Shin. 2000. Increased expression of p53 and Bax in the spinal cords of rats with experimental autoimmune encephalomyelitis. Neurosci. Lett. 289:41–44.
   PubMedGoogle Scholar
• Mora, A., K. Sakamoto, E. J. McManus, and D. R. Alessi. 2005. Role of the PDK1-PKB-GSK3 pathway in regulating glycogen synthase and glucose uptake in the heart. FEBS Lett. 579:3632–3638.
   PubMed Web of Science ®Google Scholar
• Newsholme, P., E. P. Haber, S. M. Hirabara, E. L. Rebelato, J. Procopio, D. Morgan, H. C. Oliveira-Emilio, A. R. Carpinelli, and R. Curi. 2007. Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity. J. Physiol. 583:9–24.
   PubMed Web of Science ®Google Scholar
• Pani, G., O. R. Koch, and T. Galeotti. 2009. The p53-p66shc-manganese superoxide dismutase (MnSOD) network: a mitochondrial intrigue to generate reactive oxygen species. Int. J. Biochem. Cell Biol. 41:1002–1005.
   PubMed Web of Science ®Google Scholar
• Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389:300–305.
   PubMed Web of Science ®Google Scholar
• Reichenbach, J., R. Schubert, D. Schindler, K. Muller, H. Bohles, and S. Zielen. 2002. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal. 4:465–469.
   PubMed Web of Science ®Google Scholar
• Sablina, A. A., A. V. Budanov, G. V. Ilyinskaya, L. S. Agapova, J. E. Kravchenko, and P. M. Chumakov. 2005. The antioxidant function of the p53 tumor suppressor. Nat. Med. 11:1306–1313.
   PubMed Web of Science ®Google Scholar
• Sakhi, S., A. Bruce, N. Sun, G. Tocco, M. Baudry, and S. S. Schreiber. 1994. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 91:7525–7529.
   PubMedGoogle Scholar
• Savage, D. B., K. F. Petersen, and G. I. Shulman. 2005. Mechanisms of insulin resistance in humans and possible links with inflammation. Hypertension 45:828–833.
   PubMed Web of Science ®Google Scholar
• Schwartzenberg-Bar-Yoseph, F., M. Armoni, and E. Karnieli. 2004. The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Res. 64:2627–2633.
   PubMed Web of Science ®Google Scholar
• Shoelson, S. E. 2006. Banking on ATM as a new target in metabolic syndrome. Cell Metab. 4:337–338.
   PubMedGoogle Scholar
• Sluss, H. K., H. Armata, J. Gallant, and S. N. Jones. 2004. Phosphorylation of serine 18 regulates distinct p53 functions in mice. Mol. Cell. Biol. 24:976–984.
   PubMedGoogle Scholar
• van Vlijmen, B. J., G. Gerritsen, A. L. Franken, L. S. Boesten, M. M. Kockx, M. J. Gijbels, M. P. Vierboom, M. van Eck, B. van De Water, T. J. van Berkel, and L. M. Havekes. 2001. Macrophage p53 deficiency leads to enhanced atherosclerosis in APOE*3-Leiden transgenic mice. Circ. Res. 88:780–786.
   PubMed Web of Science ®Google Scholar
• Viollet, B., F. Andreelli, S. B. Jorgensen, C. Perrin, D. Flamez, J. Mu, J. F. Wojtaszewski, F. C. Schuit, M. Birnbaum, E. Richter, R. Burcelin, and S. Vaulont. 2003. Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem. Soc. Trans. 31:216–219.
   PubMedGoogle Scholar
• Vousden, K. H., and D. P. Lane. 2007. p53 in health and disease. Nat. Rev. Mol. Cell Biol. 8:275–283.
   PubMed Web of Science ®Google Scholar
• Watters, D. J. 2003. Oxidative stress in ataxia telangiectasia. Redox Rep. 8:23–29.
   PubMed Web of Science ®Google Scholar
• Werner, H., E. Karnieli, F. J. Rauscher, and D. LeRoith. 1996. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. U. S. A. 93:8318–8323.
   PubMed Web of Science ®Google Scholar
• Xu, Y., T. Ashley, E. E. Brainerd, R. T. Bronson, M. S. Meyn, and D. Baltimore. 1996. Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma. Genes Dev. 10:2411–2422.
   PubMed Web of Science ®Google Scholar
• Yamanishi, Y., D. L. Boyle, M. J. Pinkoski, A. Mahboubi, T. Lin, Z. Han, N. J. Zvaifler, D. R. Green, and G. S. Firestein. 2002. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am. J. Pathol. 160:123–130.
   PubMed Web of Science ®Google Scholar
• Yeung, S. J., J. Pan, and M. H. Lee. 2008. Roles of p53, MYC and HIF-1 in regulating glycolysis—the seventh hallmark of cancer. Cell. Mol. Life Sci. 65:3981–3999.
   PubMed Web of Science ®Google Scholar
• Zheng, S. J., S. E. Lamhamedi-Cherradi, P. Wang, L. Xu, and Y. H. Chen. 2005. Tumor suppressor p53 inhibits autoimmune inflammation and macrophage function. Diabetes 54:1423–1428.
   PubMedGoogle Scholar